COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,429 Articles (22,835 medRxiv, 8,594 bioRxiv)

Most recent first Previous |  Page 378: Articles 3771-3780  | Next

COVID-19 Symptoms and Immunotherapy in People with Multiple Sclerosis: An Analysis of the COVID-19 in MS Global Data Sharing Initiative Dataset
Garcia-Dominguez, M. A., Srichawla, B. S., Kipkorir, V.
10.1101/2023.08.23.23294509 — Posted: 2023-08-24
SARS-CoV-2 shedding and evolution in immunocompromised hosts during the Omicron period: a multicenter prospective analysis
Raglow, Z., Surie, D., Chappell, J. D., Zhu, Y., Martin, E. T., Kwon, J. H., Frosch, A. E., Mohamed, A., Gilbert, J., Bendall, E. E., Bahr, A., Halasa, N., Talbot, H. K., Grijalva, C. G., Baughman, A., Womack, K. N., Johnson, C., Swan, S. A., Koumans, E., McMorrow, M. L., Harcourt, J. L., Atherton, L. J., Burroughs, A., Thornburg, N. J., Self, W. H., Lauring, A. S.
10.1101/2023.08.22.23294416 — Posted: 2023-08-24
Administration of vaccine-boosted COVID-19 convalescent plasma to SARS-CoV-2 infected hamsters decreases virus replication in lungs and hastens resolution of the infection despite transiently enhancing disease and lung pathology.
Carroll, T., Wong, T., Morris, M. K., Di Germanio, C., Ma, Z.-M., Stone, M., Ball, E. E., Fritts, L., Rustagi, A., Simmons, G., Busch, M. P., Miller, C. J.
10.1101/2023.08.22.553458 — Posted: 2023-08-23
Recurrent SARS-CoV-2 mutations at Spike D796 evade antibodies from pre-Omicron convalescent and vaccinated subjects
Elko, E. A., Mead, H., Nelson, G. A., Zaia, J., Ladner, J. T., Altin, J. A.
10.1101/2023.08.22.554362 — Posted: 2023-08-23
Ensemble-Based Modeling of the SARS-CoV-2 Omicron BA.1 and BA.2 Spike Trimers and Systematic Characterization of Cryptic Binding Pockets in Distinct Functional States : Emergence of Conformation-Sensitive and Variant-Specific Allosteric Binding Sites
Verkhivker, G., Alshahrani, M., Gupta, G.
10.1101/2023.08.21.554193 — Posted: 2023-08-23
The impact of Gam-COVID-Vac, an AdV5/AdV26 COVID-19 vaccine, on the biomarkers of endothelial function, coagulation and platelet activation
Turmukhambetova, A., Yegorov, S., Korshukov, I., Barkhanskaya, V., Kolesnichenko, S., Klyuyev, D., Zhumadilova, Z., Pralieva, A., Absaghit, L., Belyayev, R., Babenko, D., Hortelano, G. H., Miller, M. S., Vazenmiller, D., Kadyrova, I.
10.1101/2023.08.22.23294400 — Posted: 2023-08-23
High proportions of post-exertional malaise and orthostatic intolerance in people living with post-COVID-19 condition: the PRIME post-COVID study
Pagen, D. M., Van Herck, M., van Bilsen, C. J., Brinkhues, S., Konings, K., den Heijer, C. D., Spruit, M. A., Hoebe, C. J., Dukers-Muijrers, N. H.
10.1101/2023.08.17.23294204 — Posted: 2023-08-23
AI-based antibody discovery platform identifies novel, diverse and pharmacologically active therapeutic antibodies against multiple SARS-CoV-2 strains
Moldovan Loomis, C., Lahlali, T., Van Citters, D., Sprague, M., Neveu, G., Somody, L., Siska, C. C., Deming, D., Asakawa, A. J., Amimeur, T., Shaver, J. M., Carbonelle, C., Ketchem, R. R., Alam, A., Clark, R. H.
10.1101/2023.08.21.554197 — Posted: 2023-08-22
Heterologous sarbecovirus receptor binding domains as scaffolds for SARS-CoV-2 receptor binding motif presentation
Hauser, B. M., Sangesland, M., Lam, E. C., St. Denis, K. J., Sheehan, M. L., Vu, M. L., Cheng, A. H., Balazs, A. B., Lingwood, D., Schmidt, A.
10.1101/2023.08.21.554179 — Posted: 2023-08-22
Enhancing t-SNE Performance for Biological Sequencing Data through Kernel Selection
Chourasia, P., Murad, T., Ali, S., Patterson, M.
10.1101/2023.08.21.554138 — Posted: 2023-08-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).